SHUBHAM PANT to Combined Modality Therapy
This is a "connection" page, showing publications SHUBHAM PANT has written about Combined Modality Therapy.
Connection Strength
0.017
-
A First-in-Human Phase 1 Study of LY3023414, an Oral PI3K/mTOR Dual Inhibitor, in Patients with Advanced Cancer. Clin Cancer Res. 2018 07 15; 24(14):3253-3262.
Score: 0.017
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.